ClinicalTrials.govpublic full text
Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects
healthy subjects, cd127/il-7rα antagonist, auto-immune diseases, inflammatory bowel diseases, ulcerative colitis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803069
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.